These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bone curvature changes can predict the impact of treatment on cartilage volume loss in knee osteoarthritis: data from a 2-year clinical trial. Raynauld JP, Pelletier JP, Delorme P, Dodin P, Abram F, Martel-Pelletier J. Rheumatology (Oxford); 2017 Jun 01; 56(6):989-998. PubMed ID: 28339999 [Abstract] [Full Text] [Related]
6. The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis. Martel-Pelletier J, Raynauld JP, Dorais M, Abram F, Pelletier JP. Rheumatology (Oxford); 2016 Apr 01; 55(4):680-8. PubMed ID: 26660640 [Abstract] [Full Text] [Related]
8. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M, Pelletier JP. Ann Rheum Dis; 2011 Jun 01; 70(6):982-9. PubMed ID: 21367761 [Abstract] [Full Text] [Related]
10. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD. Arthritis Rheum; 2002 Oct 01; 46(10):2613-24. PubMed ID: 12384919 [Abstract] [Full Text] [Related]
11. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, Beaulieu AD, Abram F, Dorais M, Vignon E, Pelletier JP, Canadian Licofelone Study Group. Ann Rheum Dis; 2009 Jun 01; 68(6):938-47. PubMed ID: 18653484 [Abstract] [Full Text] [Related]
15. Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial. Henrotin Y, Berenbaum F, Chevalier X, Marty M, Richette P, Rannou F. BMC Musculoskelet Disord; 2017 May 26; 18(1):222. PubMed ID: 28549430 [Abstract] [Full Text] [Related]
18. Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis. Wu J, Wang K, Xu J, Ruan G, Zhu Q, Cai J, Ren J, Zheng S, Zhu Z, Otahal P, Ding C. Osteoarthritis Cartilage; 2017 Sep 26; 25(9):1428-1435. PubMed ID: 28602782 [Abstract] [Full Text] [Related]